rs876657686
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PM4PP3PP5_Very_Strong
The NM_001399.5(EDA):c.659_676delCAGGTCCTCCTGGTCCTC(p.Pro220_Pro225del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001399.5 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 21
GnomAD4 genome Cov.: 21
ClinVar
Submissions by phenotype
Hypohidrotic X-linked ectodermal dysplasia Pathogenic:3
The p.Pro220_Pro225del variant in EDA has been reported in 4 individuals (3 mal es, 1 female) with clinical features of XLHED (Bayes 1998, Schneider 2011, Zhang 2011). This variant results in an in-frame deletion of 18 amino acids from the conserved Gly-X-Y repeat region of the collagen subdomain of the EDA protein. Se veral adjacent in-frame and frameshift deletions have also been identified in pa tients with clinical features of XLHED (Bayes 1998, Cluzeau 2011, Zhang 2011, LM M unpublished data), indicating that this region is intolerant to these types of variation. In summary, this variant meets our criteria to be classified as path ogenic for hypohidrotic ectodermal dysplasia in an X-linked manner. -
- -
This variant, c.659_676del, results in the deletion of 6 amino acid(s) of the EDA protein (p.Pro220_Pro225del), but otherwise preserves the integrity of the reading frame. This variant is not present in population databases (gnomAD no frequency). This variant has been observed in individuals with ectodermal dysplasia (PMID: 9736768, 21357618, 27305980). ClinVar contains an entry for this variant (Variation ID: 228338). This variant disrupts a region of the EDA protein in which other variant(s) (p.Pro220Leu) have been determined to be pathogenic (PMID: 25846883). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:2
- -
In-frame deletion of 6 amino acids in a non-repeat region predicted to critically alter the protein; Not observed at a significant frequency in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27305980, 25140498, 9736768, 20979233, 30394555, 24279917, 34573371, 21357618, 23553579, 24715423, 21457804, 26345974, 31924237) -
Anhidrotic ectodermal dysplasia Pathogenic:1
Variant summary: EDA c.659_676del18 (p.Pro220_Pro225del) results in an in-frame deletion that is predicted to remove 6 amino acids from the encoded protein. The variant was absent in 146336 control chromosomes (gnomAD). c.659_676del18 has been reported in the literature in in both male and female individuals affected with Hypohidrotic Ectodermal Dysplasia, including a de novo occurrence (e.g. Bayes_1998, Schneider_2011, Cluzeau_2011, Ahmed_2021). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 9736768, 21357618, 20979233, 34573371). Five clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at